Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000840243 | SCV000982165 | likely benign | not provided | 2021-06-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001493378 | SCV001698003 | likely benign | Long QT syndrome | 2023-12-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002352486 | SCV002620664 | likely benign | Cardiovascular phenotype | 2020-03-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003928311 | SCV004741286 | likely benign | KCNJ5-related disorder | 2019-09-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |